As of Jul 21
| -0.43 / -0.50%|
The 29 analysts offering 12-month price forecasts for Novartis have a median target of 85.52, with a high estimate of 106.63 and a low estimate of 71.54. The median estimate represents a +0.63% increase from the last price of 84.99.
The current consensus among 33 polled investment analysts is to Hold stock in Novartis. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.